Skip to main content
Summary
Profile
Financials
Events
Ownership
Options

Company Info

Industry Biotechnology
Sector Health Technology
Employees 78
CEO Mr. William H. Collier
Address 701 Veterans Circle , Warminster, PA 18974
Phone 1.267.469.0914
Website www.arbutusbio.com

Arbutus Biopharma Corp. is a biopharmaceutical company. It engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.

Competitors

Company Name 3 Month
%Change
1 Year
%Change
Arbutus Biopharma Corp. 50.74% 40.48%
Janux Therapeutics, Inc. -13.30% n/a
Imago BioSciences, Inc. 70.63% n/a
Rani Therapeutics Holdings, Inc. n/a n/a
BioAtla, Inc. -26.14% n/a

Statement Summary

as of 4:00 ET PM 10/27/2021
Total Assets (MRQ) 135.4 M
Total Liabilities (MRQ) 34.5 M
Shareholders’ Equity (MRQ) 100.8 M
Total Revenue (Annual) 2.3 M
Net Income (Annual) -19.4 M

Earnings And Estimates

as of 4:00 ET PM 10/27/2021

Current Qtr EPS Estimate -0.24
Current FY EPS Estimate -0.90
Long Term EPS Growth Estimate 15.00
Next Expected Earnings Date //

ABUS vs S&P 500

as of 10/27/2021
Relative To
S&P 500
ABUS
4 Weeks n/a n/a
12 Weeks n/a n/a
YTD n/a n/a

Earnings Surprises

as of 4:00 ET PM 10/27/2021
Fiscal Quarter Estimate Actual Surprise
06/2021 -0.23 -0.23 +2.22%
03/2021 -0.23 -0.21 -9.26%
12/2020 -0.22 -0.24 +7.63%
09/2020 -0.22 -0.27 +25.00%
06/2020 -0.24 -0.25 +4.17%
03/2020 -0.31 -0.25 -20.38%
12/2019 -0.36 -0.46 +27.07%
09/2019 -0.27 -1.50 +466.04%

Financial Strength

as of 4:00 ET PM 10/27/2021
Pre-Tax Margin -832.42
Net Margin 10.54
Operating Margin -770.63
Return On Equity -86.05
Return On Assets -61.43
Inventory Turnover (TTM) 0.00
Sales Growth (MRQ) -22.59

Ratios

as of 4:00 PM ET 10/27/2021
Price/Earnings (TTM) n/a
Price/Book (MRQ) 0.00
Price/Cash Flow (TTM) 0.00
Book Value (MRQ) -0.56
Quick Ratio (MRQ) 9.44
Current Ratio (MRQ) 9.44
Total Debt/Equity (MRQ) 0.22

Short Interest

as of 12:29 PM ET 10/28/2021
% Short - 0.00%
% Remaining Float - 100.00%
Current Last Month
Short Interest Date n/a n/a
Short Interest Shares 0 0
Short Interest Ratio 0.0 0.0
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00 0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00 0,0.00
Cash from
Activities
0,0.00 0,0.00
Cash from
Fin. Activities
0,0.00 0,0.00

TOTAL ASSETS

TOTAL LIABILITIES

TOTAL EQUITY

Balance Sheet

M Y
ASSETS
Cash And Equivalents 0,0.00
Receivables 0,0.00
Inventories 0,0.00
Other Current Assets 0,0.00
Total Current Assets 0,0.00
Property, Plant & Equipment, Gross 0,0.00
Accumulated Depreciation & Depletion 0,0.00
Property, Plant & Equipment, Net 0,0.00
Intangibles 0,0.00
Other Non-Current Assets 0,0.00
Total Non-Current Assets 0,0.00
TOTAL ASSETS 0,0.00
Liabilities & Shareholder Equity
Accounts Payable 0,0.00
Short Term Debt 0,0.00
Total Current Liabilities 0,0.00
Long Term Debt 0,0.00
Deferred Income Taxes 0,0.00
Other Non-Current Liabilities 0,0.00
Minority Interest 0,0.00
Total Non-Current Liabilities 0,0.00
Preferred Stock Equity 0,0.00
Common Stock Equity 0,0.00
Common Par 0,0.00
Additional Paid In Capital 0,0.00
Cumulative Translation Adjustment 0,0.00
Retained Earnings 0,0.00
Treasury Stock 0,0.00
Other Equity Adjustments 0,0.00
Total Capitalization 0,0.00
TOTAL EQUITY 0,0.00
TOTAL LIABILITIES & STOCK EQUITY 0,0.00
Total Common Shares Outstanding 0,0.00
Preferred Shares 0,0.00
Treasury Shares 0,0.00
Basic Weighted Shares Outstanding 0,0.00
Diluted Weighted Shares Outstanding 0,0.00
Number Of Employees 0,0.00
Number Of Part-Time Employees 0,0.00

TOTAL REVENUES

EBT Excluding Unusual Items

NET INCOME

Income Statement

M Y
Sales 0,0.00
Cost Of Sales 0,0.00
Gross Operating Profit 0,0.00
Selling, General, And Administrative Expenses 0,0.00
Research & Development 0,0.00
Operating Income Before D & A (EBITDA) 0,0.00
Depreciation & Amortization 0,0.00
Interest Income 0,0.00
Other Income - Net 0,0.00
Special Income / Charges 0,0.00
Total Income Before Interest Expenses (EBIT) 0,0.00
Interest Expense 0,0.00
Pre-Tax Income 0,0.00
Income Taxes 0,0.00
Minority Interest 0,0.00
Net Income From Continuing Operations 0,0.00
Net Income From Discontinued Operations 0,0.00
Net Income From Total Operations 0,0.00
Extraordinary Income/Losses 0,0.00
Income From Cum. Effect Of Acct. Change 0,0.00
Income From Tax Loss Carryforward 0,0.00
Other Gains / Losses 0,0.00
Total Net Income 0,0.00
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Preferred Dividends 0,0.00
Net Income Available To Common 0,0.00
Basic EPS From Continuing Ops. 0,0.00
Basic EPS From Discontinued Ops. 0,0.00
Basic EPS From Total Operations 0,0.00
Basic EPS From Extraordinary Inc. 0,0.00
Basic EPS From Cum Effect Of Accounting Change 0,0.00
Basic EPS From Tax Loss Carryf'd. 0,0.00
Basic EPS From Other Gains (Losses) 0,0.00
Basic EPS, Total 0,0.00
Basic Normalized Net Income/Share 0,0.00
EPS From Continuing Ops. 0,0.00
EPS From Discontinued Ops 0,0.00
EPS From Total Ops. 0,0.00
EPS From Extraord. Inc. 0,0.00
EPS From Cum Effect of Accounting Change 0,0.00
EPS From Tax Loss Carfd. 0,0.00
EPS From Other Gains (L) 0,0.00
EPS, Total 0,0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Dividends Paid Per Share 0,0.00

CASH FROM OPERATIONS

CASH FROM INVESTING ACTIVITIES

CASH FROM FINANCING ACTIVITIES

Cash Flow Statement

M Y
Cash Flow From Operating Activities
Net Income (Loss) 0,0.00
Operating Gains/Losses 0,0.00
Gross Operating Profit 0,0.00
(Increase) Decrease In Receivables 0,0.00
(Increase) Decrease In Inventories 0,0.00
(Increase) Decrease In Other Current Assets 0,0.00
(Decrease) Increase In Other Current Liabilities 0,0.00
(Increase) Decrease In Other Working Capital 0,0.00
Other Non-Cash Items 0,0.00
Net Cash From Continuing Operations 0,0.00
Net Cash From Discontinued Operations 0,0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0,0.00
Sale Of Property, Plant & Equipment 0,0.00
Cash Used For Investing Activities
Sale Of Short-Term Investments 0,0.00
Purchases Of Property, Plant & Equipment 0,0.00
Acquisitions 0,0.00
Purchases Of Short-Term Investments 0,0.00
Other Cash From Investing Activities 0,0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 0,0.00
Issuance Of Debt 0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock 0,0.00
Repayment Of Long-Term Debt 0,0.00
Repurchase Of Capital Stock 0,0.00
Payment Of Cash Dividends 0,0.00
Other Financing Charges, Net 0,0.00
Net Cash From Financing Activities 0,0.00
Effect Of Exchange Rate Changes 0,0.00
Net Change In Cash & Cash Equivalents 0,0.00

Earnings Estimates

as of 4:00 ET PM 10/27/2021
Current Qtr
(09/2021)
Next Qtr
(12/2021)
Consensus Estimate $-0.24 $-0.22
# of Estimates 5 5
High Estimate $-0.23 $-0.19
Low Estimate $-0.25 $-0.24
Year Ago EPS $-0.23 $-0.23
Year Over Year Growth Estimate 3.30% -3.65%
Current Yr
(12/2021)
Next Yr
(12/2022)
Consensus Estimate $-0.90 $-0.82
# of Estimates 5 5
High Estimate $-0.85 $-0.61
Low Estimate $-0.93 $-1.02
Year Ago EPS $-1.00 $-0.90
Year Over Year Growth Estimate -10.40% -8.93%
Current Qtr
(09/2021)
Next Qtr
(12/2021)
Current Year
(12/2021)
Next Year
(12/2022)
Consensus Estimate $-0.24 $-0.22 $-0.90 $-0.82
# of Estimates 5 5 5 5
High Estimate $-0.23 $-0.19 $-0.85 $-0.61
Low Estimate $-0.25 $-0.24 $-0.93 $-1.02
Year Ago EPS $-0.23 $-0.23 $-1.00 $-0.90
Year Over Year Growth Estimate 3.30% -3.65% -10.40% -8.93%

Insider Information Summary

as of 09/30/2021
% Insiders - 19.24%
% Remaining Total Shares - 80.76%
Current 1 Month
Net Insider Transaction 0.00 0.00
Shares Bought 0.00 0.00
Shares Sold 0.00 0.00

Insider Activity

Transaction Date Insider/Title Transaction Type Market Value Shares Average Price Current Holdings

LATEST NEWS

Recent Articles from TheStreet

china-manufacturing-stanley-black-amp-decker-shuts-shenzhen-factory-as-costs-soar

Stanley Black & Decker Shares Dip as Inflation Hits Guidance

'Commodity and supply chain headwinds' could cause $690 million of costs this year and $600 million-$650 million in 2022, Stanley Black & Decker says.

Ford Lead

Ford Motor Stock Rallied. Here's Its Must-Hold Level.

Ford stock is hitting a seven-year high on better-than-expected earnings. Here's how we're managing the trade from here.

BJ's Wholesale May Be for Sale, Piques Amazon's Interest

BJ's Wholesale Cut to Neutral; Bank of America Sees Headwinds

BJ's 'near-term headwinds' include 'delayed cost pass-throughs, supply chain challenges, etc.,' Bank of America says.

China Stocks Extend Losses As Markets Struggle With Valuation, Rising Bond Yields

Nasdaq Hits Record, Caterpillar and Merck Lift Dow, GDP Slumps

The Nasdaq hits an intraday high as solid earnings reports drives markets higher.

Ford Lead

5 Top Stock Gainers for Thursday: Ford, LendingClub, Anheuser-Busch

Ford, LendingClub,Anheuser-Busch, Overstock.com and 1-800-Flowers.com are five top stock gainers for Thursday.

shopify-has-impressive-momentum-but-is-it-worth-the-price-tag

Shopify Shares Rise on 46% Surge in Q3 Revenue

Shopify shares rose after the sales platform reported higher third-quarter profit after an investment gain on 46% revenue growth.

Cathie Wood Lead

Cathie Wood Still Bullish on Robinhood: Ark Bought Shares

Ark Investment Management on Wednesday purchased 2.24 million shares of brokerage app Robinhood, now valued at about $78 million.

Sorry Starbucks Workers: A Barista Is Among the 5 Lowest-Paying Jobs in America

Starbucks to Raise Wages to Average $17-Hour by Summer 2022

Starbucks will have a base salary of $15 an hour with the average worker being $17 per hour by summer 2022.

Global Foundries Lead

Chipmaker GlobalFoundries Falls in Stock Market Debut

Chipmaker GlobalFoundries made its trading debut Thursday at $44.51 a share, 5% down from its initial public offering price of $47.

LendingClub Appoints New CEO, Cuts 179 Jobs

LendingClub Stock Leaps on Earnings Beat, Year Guidance

LendingClub had a stronger-than-expected third quarter and raised its full-year guidance. The stock is up double digits.